Diabetes News and Research

Latest Diabetes News and Research

Physicians call for large clinical trials to assess risks associated with testosterone treatment

Physicians do not have sufficient information from clinical trials to understand the risks associated with the prescription of testosterone in older men, according to a Comment in The Lancet Diabetes & Endocrinology, written by Professor Stephanie Page, of the University of Washington and Harborview Medical Center, Seattle, USA.

29 Apr 2014

Study: Genetics as well as environment in womb play important roles in development of baby

A recent study led by A*STAR's Singapore Institute for Clinical Sciences (SICS) found that genetics as well as the environment in the womb play important roles in the development of the baby.

29 Apr 2014

People who take statin drugs develop heart disease and obesity-related illnesses

People who take statin drugs to lower their cholesterol appear to have developed a false sense of security that could lead to heart disease and other obesity-related illnesses.

29 Apr 2014

Caring for homeless people: Housing first, treatment later

Providing safe, stable and affordable housing first is the best way to help homeless in Hamilton, Ont., according to new research.

29 Apr 2014

Severe diabetes linked to brain atrophy

Type 2 diabetes may be associated with brain degeneration, according to a new multicenter study published online in the journal Radiology. The study also found that, contrary to common clinical belief, diabetes may not be directly associated with small vessel ischemic disease, where the brain does not receive enough oxygenated blood.

29 Apr 2014

Researchers detect correlation between loss of Y chromosome and risk of cancer mortality

...

29 Apr 2014

Research to understand how low blood sugars cause irregular heartbeats in diabetes

Dangerous overnight blood sugar levels often go undetected and cause prolonged periods of heart rhythm disturbances in older patients with Type 2 diabetes and associated heart problems, new research reveals.

29 Apr 2014

Girls labeled fat at age 10 are more likely to be obese at 19, say researchers

Girls who are told by a parent, sibling, friend, classmate or teacher that they are too fat at age 10 are more likely to be obese at age 19, a new study by UCLA psychologists shows.

29 Apr 2014

BRCA gene loss may accelerate cancer-promoting chromosome rearrangements

Inherited mutations in the BRCA1 or BRCA2 tumor suppressor genes are by far the most frequent contributors to hereditary cancer risk in the human population, often causing breast or ovarian cancer in young women of child-bearing age.

29 Apr 2014

Adherence optimises success of primary care hypertension programme

The value of a structured hypertension-treatment programme in primary care increases with increasing adherence to the programme, say researchers.

28 Apr 2014

GSK, Theravance announce availability of Anoro Ellipta in the US for COPD treatment

GlaxoSmithKline plc and Theravance, Inc. today announced that Anoro Ellipta (umeclidinium and vilanterol inhalation powder), the first once-daily product approved in the US that combines two long-acting bronchodilators in a single inhaler for the maintenance treatment of chronic obstructive pulmonary disease (COPD), is now available to retail pharmacies in the US.

28 Apr 2014

Young onset age heightens Type 2 diabetes complication risks

Patients who develop Type 2 diabetes before the age of 40 years have higher complication risks at any given age than those who develop it later in life, research shows.

28 Apr 2014

Australian and New Zealand patients with diabetes-induced vision loss to get access to new treatment

Australian and New Zealand patients suffering from vision impairment due to a type of diabetes-induced eye disease will have access to a new treatment, following a license deal between Australian biopharmaceutical company Specialised Therapeutics Australia and Alimera Sciences.

28 Apr 2014

Voluntis closes €20.75 million ($29 million) Series D financing round

Voluntis, a company pioneering therapeutic companion software, today announced the completion of its Series D financing round. With a total of €20.75 million ($29 million), this fund raising is one of the largest rounds of investment in the m-health sector this year.

28 Apr 2014

European Commission approves VOKANAMET for treatment of adults with type 2 diabetes mellitus

Janssen-Cilag International NV (Janssen) announced today that the European Commission (EC) has approved VOKANAMET® (a fixed-dose therapy combining canagliflozin and immediate release metformin hydrochloride in a single tablet) in the European Union, for the treatment of adults with type 2 diabetes mellitus to improve glycaemic control.

26 Apr 2014

Professor wins 2014 Outstanding Scientific Achievement Award from American Diabetes Association

Dr. Joel Elmquist, Director of the Center for Hypothalamic Research at UT Southwestern Medical Center, has been awarded the American Diabetes Association's Outstanding Scientific Achievement Award, the organization's top honor for an early-career scientist.

26 Apr 2014

Diabetes News and Research

Latest Diabetes News and Research

Physicians call for large clinical trials to assess risks associated with testosterone treatment

Study: Genetics as well as environment in womb play important roles in development of baby

People who take statin drugs develop heart disease and obesity-related illnesses

Caring for homeless people: Housing first, treatment later

Severe diabetes linked to brain atrophy

Researchers detect correlation between loss of Y chromosome and risk of cancer mortality

Research to understand how low blood sugars cause irregular heartbeats in diabetes

Girls labeled fat at age 10 are more likely to be obese at 19, say researchers

BRCA gene loss may accelerate cancer-promoting chromosome rearrangements

Adherence optimises success of primary care hypertension programme

GSK, Theravance announce availability of Anoro Ellipta in the US for COPD treatment

Young onset age heightens Type 2 diabetes complication risks

Australian and New Zealand patients with diabetes-induced vision loss to get access to new treatment

Voluntis closes €20.75 million ($29 million) Series D financing round

European Commission approves VOKANAMET for treatment of adults with type 2 diabetes mellitus

Professor wins 2014 Outstanding Scientific Achievement Award from American Diabetes Association

Most men suffered TBI before becoming homeless

Johns Hopkins research may help manage the disruptive effects experienced by shift workers

Discovery offers potential target for reversing progression of end-stage liver disease

New study sheds light on mysterious gene that influences cardiovascular health

Genomics - Industry Focus eBook (2nd edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Diabetes News and Research

Latest Diabetes News and Research

Genomics - Industry Focus eBook (2nd edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in